BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35654712)

  • 1. Are we missing reverse TRALI? - A real world experience from a tertiary care oncology centre in India.
    Basu D; Basu S; Datta SS
    Transfus Apher Sci; 2022 Dec; 61(6):103466. PubMed ID: 35654712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
    Jug R; Anani W; Callum J
    Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
    Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
    Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are we underestimating reverse TRALI?
    De Clippel D; Emonds MP; Compernolle V
    Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of transfusion-related acute lung injury triggered by HLA and anti-HLA antibody reaction.
    Lee JH; Kang ES; Kim DW
    J Korean Med Sci; 2010 Sep; 25(9):1398-403. PubMed ID: 20808691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-related acute lung injury: current concepts for the clinician.
    Triulzi DJ
    Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TRALI is an overlooked severe complication related to blood transfusion].
    Haunstrup TM; Baech J; Varming K; Rasmussen BS; Nielsen KR
    Ugeskr Laeger; 2014 Mar; 176(7):. PubMed ID: 25096345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013.
    Andreu G; Boudjedir K; Muller JY; Pouchol E; Ozier Y; Fevre G; Gautreau C; Quaranta JF; Drouet C; Rieux C; Mertes PM; Clavier B; Carlier M; Sandid I
    Transfus Med Rev; 2018 Jan; 32(1):16-27. PubMed ID: 28864336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components.
    Kleinman SH; Triulzi DJ; Murphy EL; Carey PM; Gottschall JL; Roback JD; Carrick D; Mathew S; Wright DJ; Cable R; Ness P; Gajic O; Hubmayr RD; Looney MR; Kakaiya RM;
    Transfusion; 2011 Oct; 51(10):2078-91. PubMed ID: 21446938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human neutrophil antibodies in a blood donor population: a lookback study.
    Gottschall J; Triulzi D; Kakaiya R; Carrick D; Roback JD; Carey P; Kleinman S;
    Vox Sang; 2013 Feb; 104(2):166-70. PubMed ID: 22998453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating transfusion-related acute lung injury (TRALI).
    Fung YL; Goodison KA; Wong JK; Minchinton RM
    Intern Med J; 2003 Jul; 33(7):286-90. PubMed ID: 12823673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenetic analysis of transfusion-related acute lung injury caused by human leukocytes antigen antibody against human leukocyte antigen].
    Deng J; Xu XZ; Ye X; Chen YK; Ding HQ; Liu J; Xia WJ; Chen DW; Xu YR
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(11):883-887. PubMed ID: 38462366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
    Flesch BK; Petershofen EK; Bux J
    Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRALI risk reduction: donor and component management strategies.
    Eder AF; Benjamin RJ
    J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reported transfusion-related acute lung injury associated with solvent/detergent plasma - A case series.
    Klanderman RB; Bulle EB; Heijnen JWM; Allen J; Purmer IM; Kerkhoffs JH; Wiersum-Osselton JC; Vlaar APJ
    Transfusion; 2022 Mar; 62(3):594-599. PubMed ID: 35174882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Incidence of Transfusion-Related Acute Lung Injury at a Large, Urban Tertiary Medical Center: A Decade's Experience.
    Meyer DE; Reynolds JW; Hobbs R; Bai Y; Hartwell B; Pommerening MJ; Fox EE; Wade CE; Holcomb JB; Cotton BA
    Anesth Analg; 2018 Aug; 127(2):444-449. PubMed ID: 29697510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-related acute lung injury: Current understanding and preventive strategies.
    Vlaar AP
    Transfus Clin Biol; 2012 Jun; 19(3):117-24. PubMed ID: 22682310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent transfusion-related acute lung injury.
    Win N; Montgomery J; Sage D; Street M; Duncan J; Lucas G
    Transfusion; 2001 Nov; 41(11):1421-5. PubMed ID: 11724989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.